Showing results (1341-1350 of 2,879) with videos related to

Sort By:
Pageof 288
Molecular Diversity|May 22, 2025
Novel pyrazole carboxylate derivatives as lonazolac bioisosteres with selective COX-2 inhibition: design, synthesis and anti-inflammatory activityWael A A Fadaly, Ahmed Elshewy, Ahmed H A Abusabaa, et al.
Molecular Diversity|May 20, 2025
Machine learning approaches for predicting the small molecule-miRNA associations: a comprehensive reviewAshish Panghalia, Vikram Singh
Molecular Diversity|April 29, 2025
GLP-1R agonists: recent advances, current gaps, and future challengesAnukriti Saran, Riya Raisinghani, Sarvesh Paliwal, et al.
Molecular Diversity|April 27, 2025
Co-development of efflux pump inhibitors with antibiotics on targeting structural and mutational aspects of AcrB subunitShweta Singh Chauhan, Tanya Jamal, Anshika Gupta, et al.
Molecular Diversity|April 28, 2025
Computational approach for the evaluation of sesquiterpene lactone as a modulator of cannabinoid receptor type 2 for neurodegenerative disease prophylacticsRam Lal Swagat Shrestha, Ashika Tamang, Sujan Dhital, et al.
Molecular Diversity|April 2, 2025
Integrating deep learning and molecular dynamics simulations for FXR antagonist discoveryYueying Yang, Yuxin Huang, Hanxiao Shen, et al.
Molecular Diversity|April 22, 2025
Rational design of structurally rigidified ketone-peptide deformylase inhibitors with enhanced membrane permeability for combating gram-negative bacterial infectionsZhonghui Zhang, Jidi Hu, Maoqing Shi, et al.
Molecular Diversity|April 19, 2025
PPI networking, in-vitro expression analysis, virtual screening, DFT, and molecular dynamics for identifying natural TNF-α inhibitors for rheumatoid arthritisYogaswaran Velmurugan, Nandhini Chakkarapani, Sathan Raj Natarajan, et al.
Molecular Diversity|March 17, 2025
Probing the dark chemical matter against PDE4 for the management of psoriasis using in silico, in vitro and in vivo approachB Swapna, Satvik Kotha, Divakar Selvaraj, et al.
Molecular Diversity|March 13, 2025
An update on current type 2 diabetes mellitus (T2DM) druggable targets and drugs targeting themPrerna Uniyal, Surbhi Panwar, Akanksha Bhatt, et al.
Pageof 288